IL1B and steatosis: On the other hand, the known effects of the CB2 receptor in modulating the inflammatory response by inhibiting NF-κB transmission into the nucleus, reducing the production of TNFα and IL-6, IL-1B and increasing IL-10 play an important role in preventing the progression of steatosis to steatohepatitis [152, 153].